Henry Fernandez steps down from Royalty Pharma board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/23/2026
- Wall St futures ease as Big Tech earnings rekindle AI spending worries, oil jumps
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- RTX stock jumps as company lifts guidance after Q2 beat
- Dollar hits fresh 40-year high versus yen, edges higher against euro
Henry Fernandez Steps Down from Royalty Pharma's Board of Directors
August 13, 2025 4:15 PM EDTNEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that Henry Fernandez, its Lead Independent Director, has stepped down from its Board of Directors, effective August 13, 2025. Mr. Fernandez joined the Royalty Pharma Board of Directors in July 2020 and was unanimously appointed as Lead Independent Director in March 2021.
We are tremendously grateful for Henry's contributions to Royalty Pharma over the past five years, said Pablo Legorreta, founder and Chief Executive Officer of Royalty Pharma. His experience as a seasoned chief executive of a public company together with his exceptional... More
